Tonix Pharmaceuticals Holding Corp (TNXP)

Jun 06, 2025

Tonix Pharmaceuticals to Showcase Rheumatologic Research at EULAR 2025 - citybuzz -

Jun 06, 2025

Jun 05, 2025

Tonix Pharmaceuticals Announces Poster Presentation at the Annua - GuruFocus

Jun 05, 2025

Jun 05, 2025

Tonix Pharmaceuticals Announces Poster Presentation at the Annual European Congress of Rheumatology (EULAR) 2025 | TNXP Stock News - GuruFocus

Jun 05, 2025

Jun 05, 2025

Tonix Pharmaceuticals Announces Poster Presentation at the - GlobeNewswire

Jun 05, 2025

Jun 04, 2025

Northern Trust Corp Acquires New Shares in Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) - Defense World

Jun 04, 2025

Jun 03, 2025

Tonix Pharmaceuticals (TNXP) Price Target Raised to $65 by Alliance Global Partners | TNXP Stock News - GuruFocus

Jun 03, 2025

Jun 01, 2025

Wall Street Zen Downgrades Tonix Pharmaceuticals (NASDAQ:TNXP) to Sell - Defense World

Jun 01, 2025

May 30, 2025

Tonix Pharmaceuticals: August PDUFA Date For Fibromyalgia Med A Risky Bet (NASDAQ:TNXP) - Seeking Alpha

May 30, 2025

May 29, 2025

Tonix Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Highlights - Revista ADVFN

May 29, 2025

May 29, 2025

How the (TNXP) price action is used to our Advantage - news.stocktradersdaily.com

May 29, 2025

May 29, 2025

Tonix Pharmaceuticals (TNXP) Stock Surges Over 10%: What's Fueling the Rally and What's Next? - Daily Chhattisgarh News

May 29, 2025

May 28, 2025

What's Going On With Tonix Pharmaceuticals Stock? - Benzinga

May 28, 2025

May 28, 2025

TNXP: Preparations Continue for Potential Commercial Launch of TNX-102 SL in Fibromyalgia… - Yahoo Finance

May 28, 2025

May 23, 2025

Tonix Pharmaceuticals CEO Highlights Strategic Vision at Healthcare Showcase - citybuzz -

May 23, 2025

May 22, 2025

Tonix Pharmaceuticals Announces Presentation at the A.G.P. Annual Healthcare Company Showcase - GlobeNewswire

May 22, 2025

May 21, 2025

Tonix begins trial for stress reaction treatment By Investing.com - Investing.com South Africa

May 21, 2025

May 21, 2025

Tonix begins trial for stress reaction treatment - Investing.com Australia

May 21, 2025

May 21, 2025

Tonix Pharmaceuticals Announces First Patient Dosed in Phase 2 O - GuruFocus

May 21, 2025

May 21, 2025

Tonix Pharmaceuticals (TNXP) Commences Phase 2 Trial for Stress Disorder Treatment | TNXP Stock News - GuruFocus

May 21, 2025

May 21, 2025

Tonix Pharmaceuticals Announces First Patient Dosed In Phase 2 Oasis Study Of TNX-102 SL For Reduction Of Acute Stress Reaction - marketscreener.com

May 21, 2025

May 21, 2025

Tonix Pharmaceuticals Announces First Patient Dosed in - GlobeNewswire

May 21, 2025

May 21, 2025

DoD Backs Revolutionary Acute Stress Treatment: First Patient Dosed in $3M Phase 2 Trial - Stock Titan

May 21, 2025

May 16, 2025

Tonix Pharmaceuticals (TNXP) Stock Surges Following Insider Buying And Q1 Results - Benzinga

May 16, 2025

May 15, 2025

Stocks To Watch: Tonix Pharmaceuticals Sees RS Rating Jump To 89 - inkl

May 15, 2025

May 14, 2025

Tonix Pharmaceuticals Recruits Seasoned Industry Atty As GC - Law360

May 14, 2025

May 14, 2025

Tonix Pharma Stock Soars After Roping In Former Celgene Corp Executive Joseph Hand: Retail Gets More Positive - Investing.com India

May 14, 2025

May 14, 2025

Tonix Pharmaceuticals Names Joseph Hand as General Counsel and Executive Vice President of Operations - citybuzz -

May 14, 2025

May 14, 2025

Tonix Pharmaceuticals Appoints Joseph Hand, Esq., as General Counsel and Executive Vice President of Operations - citybiz

May 14, 2025

May 14, 2025

Tonix Pharmaceuticals (TNXP) Appoints New General Counsel and EV - GuruFocus

May 14, 2025

May 14, 2025

Tonix Pharmaceuticals (TNXP) Appoints New General Counsel and EVP of Operations | TNXP Stock News - GuruFocus

May 14, 2025

May 14, 2025

Tonix Pharma Appoints New General Counsel and EVP - TipRanks

May 14, 2025

May 14, 2025

Tonix Pharmaceuticals Announces Appointment of Joseph Hand, - GlobeNewswire

May 14, 2025

May 14, 2025

Former Celgene $74B Deal Leader Joins Tonix as EVP Before Critical Fibromyalgia Drug Decision - Stock Titan

May 14, 2025

May 13, 2025

Tonix Pharmaceuticals Reports First Quarter 2025 Financial Resul - GuruFocus

May 13, 2025

May 13, 2025

Tonix Pharmaceuticals Q1 2025 Earnings: EPS Loss of $2.84 Beats - GuruFocus

May 13, 2025

May 12, 2025

Tonix Pharmaceuticals Holding Corp reports results for the quarter ended March 31Earnings Summary - TradingView

May 12, 2025

May 12, 2025

Tonix Pharma earnings beat by $22.84, revenue fell short of estimates - Investing.com

May 12, 2025

May 09, 2025

Tonix Pharmaceuticals reports annual meeting results By Investing.com - Investing.com Nigeria

May 09, 2025

May 09, 2025

Tonix Pharmaceuticals reports annual meeting results - Investing.com Australia

May 09, 2025

May 08, 2025

Tonix showcases promising gastric cancer data at AACR Conference - Proactive financial news

May 08, 2025

May 08, 2025

(TNXP) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com

May 08, 2025

May 07, 2025

Tonix Pharma drops after Q4 revenue miss - MSN

May 07, 2025

May 06, 2025

Tonix Pharmaceuticals: Looking Past FDA Approval To Challenging Commercial Opportunity - Seeking Alpha

May 06, 2025

Apr 29, 2025

Tonix Pharmaceuticals Reveals Promising Preclinical Data for Cancer Immunotherapy TNX-1700 - citybuzz -

Apr 29, 2025

Apr 29, 2025

Tonix Pharma Unveils Promising Cancer Treatment Data - TipRanks

Apr 29, 2025

Apr 29, 2025

Tonix Pharmaceuticals Presented Preclinical Data on Gastric - GlobeNewswire

Apr 29, 2025

Apr 29, 2025

Tonix Pharmaceuticals (TNXP) Showcases Promising Cancer Research at AACR 2025 | TNXP Stock News - GuruFocus

Apr 29, 2025

Apr 29, 2025

Tonix Pharmaceuticals Presented Preclinical Data on Gastric Canc - GuruFocus

Apr 29, 2025